Independent review adds to controversy at Sick Kids

CMAJ. 1999 Feb 9;160(3):386-8.
No abstract available

MeSH terms

  • Advisory Committees
  • Biomedical Research*
  • Child
  • Child Welfare*
  • Clinical Trials as Topic
  • Conflict of Interest*
  • Contracts
  • Deferiprone
  • Disclosure*
  • Drug Industry
  • Ethics, Medical
  • Humans
  • Iron Chelating Agents / adverse effects*
  • Iron Chelating Agents / therapeutic use
  • Journalism, Medical
  • Liability, Legal*
  • Minors
  • Ontario
  • Professional Misconduct
  • Pyridones / adverse effects*
  • Pyridones / therapeutic use
  • Thalassemia / drug therapy
  • Therapeutic Human Experimentation
  • Truth Disclosure*
  • Whistleblowing

Substances

  • Iron Chelating Agents
  • Pyridones
  • Deferiprone